Status in the Senate - 91st Legislature (2019 - 2020)
Insulin products commissioner of health costs review authorization; excess costs determination; maximum reimbursement level establishment; appropriation
| 01/22/2019 | |
| 01/22/2019 |
Referred to
Health and Human Services Finance and Policy
|
| Senate Actions | House Actions |
|---|---|
| 01/22/2019 | |
|
Referred to
Health and Human Services Finance and Policy
|
|